This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors.
Endocrine, 87(3), 1333-1341
Citation
Mamulashvili Bessac, Darejan; Baltzinger, Philippe; Poterszman, Nathan; Pham Van, Floriane; Collen, Cedric; Malouf, Gabriel G; Ouvrard, Eric; Kaseb, Ashjan; Porot, Clemence; Ben Abdelghani, Meher; Addeo, Pietro; Mertz, Luc; Goichot, Bernard; Imperiale, Alessio. (2025). Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors.. Endocrine, 87(3), 1333-1341. https://doi.org/10.1007/s12020-024-04138-y